Combination HRT raises women's risk of lung cancer

02/25/2010 | Reuters

Hormone replacement therapy containing estrogen and progestin increases the risk of lung cancer in women, according to study data. Women who used the combination HRT for 10 years or more were almost 50% more likely to be diagnosed with lung cancer compared with nonusers, even after taking into consideration age and smoking history.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX